[Neuropathies in small cell lung cancer]

Area of Science:

• Neurology
• Oncology

Context:

• Small cell lung cancer (SCLC) is a highly aggressive malignancy.
• Neurological complications can affect cancer patients, impacting quality of life.
• Early detection of neurological issues is crucial for management.

Purpose:

• To evaluate the prevalence and characteristics of peripheral nervous system (PNS) injury in SCLC patients before chemotherapy.
• To assess the utility of neurological examination and electromyography (EMG) in detecting subclinical neuropathy.

Summary:

• A study involving 65 SCLC patients before chemotherapy used neurological exams and EMG to assess PNS integrity.
• Neuropathy was suspected in 34% and confirmed by EMG, with 12 patients showing subclinical neuropathy.
• Overall, 52% of patients exhibited PNS injury, including sensory, motor-sensory, and motor neuropathies. One case of Eaton-Lambert syndrome and evidence of anterior horn cell injury were noted.

Impact:

• Findings indicate a high incidence of peripheral neuropathy in SCLC patients, often subclinical.
• Highlights the importance of routine neurological screening and EMG in this population.
• Suggests potential for early intervention to mitigate neurological deficits and improve patient outcomes.